NinePoint Medical

NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, announced that it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Nvision VLE Imaging System, expanding the system’s indication to include imaging of esophageal tissue microstructure. In Jan. 2012, the company announced 510(k) clearance from the FDA to market its Nvision VLE Imaging System for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross sectional, real-time depth visualization.